Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Diagnostic Pathology
|
October 24, 2008
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH)
Hiroaki Nitta, Beatrice Hauss-Wegrzyniak, Megan Lehrkamp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma
Robin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Blood
|
March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Robin A Roberts, George Wright, Andreas R Rosenwald, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2013
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay
Hiroaki Nitta, Koji Tsuta, Akihiko Yoshida, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Haematologica
|
September 9, 2010
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas
Scott J Rodig, Jeffery L Kutok, Jennifer C Paterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
Itziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Blood
|
February 21, 2004
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Lisa M Rimsza, Robin A Roberts, Thomas P Miller, et al.
Blood
|
October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
Lisa M Rimsza, Robin A Roberts, Elias Campo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
Javeed Iqbal, Vishala T Neppalli, George Wright, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Diagnostic Pathology
|
October 24, 2008
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH)
Hiroaki Nitta, Beatrice Hauss-Wegrzyniak, Megan Lehrkamp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma
Robin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Blood
|
March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Robin A Roberts, George Wright, Andreas R Rosenwald, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2013
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay
Hiroaki Nitta, Koji Tsuta, Akihiko Yoshida, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Haematologica
|
September 9, 2010
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas
Scott J Rodig, Jeffery L Kutok, Jennifer C Paterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
Itziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Blood
|
February 21, 2004
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Lisa M Rimsza, Robin A Roberts, Thomas P Miller, et al.
Blood
|
October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
Lisa M Rimsza, Robin A Roberts, Elias Campo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
Javeed Iqbal, Vishala T Neppalli, George Wright, et al.
Page
of 6